This service is needed to test the efficacy a lambda phage vaccine engineered with segments of the covid-19 spike protein antigen in an animal model.
Ended Purchase Order Awarded
- Contract number
- 75N91022P00832
- Awardee
-
Integrated Biotherapeutics, LLC UEI XNTHMSN2JJP5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,869
Award facts
- Contract value 100% obligated
- $16,869.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91022P00832?
75N91022P00832 was awarded to Integrated Biotherapeutics, LLC by National Cancer Institute (National Institutes of Health) on August 28, 2022.
How much is contract 75N91022P00832 worth?
The government has obligated $16,869 on 75N91022P00832.
Was contract 75N91022P00832 competed?
The extent of competition for 75N91022P00832 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award